by Dan Roberts Autonomous (driverless) vehicles are on the way. The technology is already in place, having been successfully tested for several years under every city and highway traveling condition. Many automakers report that their new cars are now being equipped for driverless operation, so the change-over will be easy when the time comes. And [Read More]
Category: Research and Developments
NIH Launches International Study of AMD Progression
Natural history investigation will deploy latest advances to identify biomarkers, targets for early therapy A new clinical study led by the National Eye Institute (NEI), part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early age-related macular degeneration (AMD). By using the [Read More]
New Stem Cell Therapy Treats Macular Degeneration
A new procedure reported in the current issue of Nature Biotechnology has been shown to be a safe and effective method for introducing stem cells into the retina. Implantation of a specially engineered patch of retinal pigment epithelium (RPE) cells derived from stem cells has restored some vision in two people with sight loss from [Read More]
First AMD Patient Receives Sub-Retinal Implant
(Updated 4/17/18) Pixium Vision has announced its first successful human implantation of a wireless sub-retinal implant in a patient with atrophic dry age-related macular degeneration (AMD). So far, three patients have been implanted with the device, and results are promising. As reported here in October 2017, the implant, called PRIMA, acts like a tiny solar [Read More]
Apellis Entering Phase 3 Trials for Dry Macular Degeneration
Apellis Pharmaceuticals has announced that it has finalized the trial design for its planned Phase 3 program evaluating APL-2 for the treatment of patients with geographic atrophy (GA), aka dry macular degeneration. The Phase 3 program, planned to begin in the second half of 2018, will consist of two identical studies to assess the efficacy [Read More]